Alnylam Pharmaceuticals Total Assets 2006-2021 | ALNY

Alnylam Pharmaceuticals total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Alnylam Pharmaceuticals total assets for the quarter ending March 31, 2021 were $3.255B, a 42.8% increase year-over-year.
  • Alnylam Pharmaceuticals total assets for 2020 were $3.407B, a 42.25% increase from 2019.
  • Alnylam Pharmaceuticals total assets for 2019 were $2.395B, a 52.09% increase from 2018.
  • Alnylam Pharmaceuticals total assets for 2018 were $1.575B, a 21.05% decline from 2017.
Alnylam Pharmaceuticals Annual Total Assets
(Millions of US $)
2020 $3,407
2019 $2,395
2018 $1,575
2017 $1,995
2016 $1,263
2015 $1,387
2014 $1,080
2013 $421
2012 $288
2011 $282
2010 $393
2009 $481
2008 $555
2007 $494
2006 $240
2005 $98
Alnylam Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2021-03-31 $3,255
2020-12-31 $3,407
2020-09-30 $3,307
2020-06-30 $3,374
2020-03-31 $2,280
2019-12-31 $2,395
2019-09-30 $2,542
2019-06-30 $2,716
2019-03-31 $2,014
2018-12-31 $1,575
2018-09-30 $1,676
2018-06-30 $1,789
2018-03-31 $1,923
2017-12-31 $1,995
2017-09-30 $1,358
2017-06-30 $1,434
2017-03-31 $1,134
2016-12-31 $1,263
2016-09-30 $1,313
2016-06-30 $1,382
2016-03-31 $1,317
2015-12-31 $1,387
2015-09-30 $1,436
2015-06-30 $1,531
2015-03-31 $1,629
2014-12-31 $1,080
2014-09-30 $986
2014-06-30 $1,033
2014-03-31 $1,080
2013-12-31 $421
2013-09-30 $448
2013-06-30 $463
2013-03-31 $472
2012-12-31 $288
2012-09-30 $322
2012-06-30 $318
2012-03-31 $340
2011-12-31 $282
2011-09-30 $310
2011-06-30 $341
2011-03-31 $369
2010-12-31 $393
2010-09-30 $413
2010-06-30 $440
2010-03-31 $463
2009-12-31 $481
2009-09-30 $496
2009-06-30 $519
2009-03-31 $555
2008-12-31 $555
2008-09-30 $580
2008-06-30 $580
2008-03-31 $486
2007-12-31 $494
2007-09-30 $505
2007-06-30 $220
2007-03-31 $227
2006-12-31 $240
2006-09-30 $145
2006-06-30 $147
2006-03-31 $154
2005-12-31 $98
2005-09-30 $43
2005-06-30 $51
2005-03-31 $59
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $20.329B $0.493B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $147.234B 10.21
Amgen (AMGN) United States $137.841B 14.87
CSL (CSLLY) Australia $103.116B 0.00
Moderna (MRNA) United States $88.882B 177.09
Gilead Sciences (GILD) United States $84.093B 8.95
Illumina (ILMN) United States $67.991B 98.04
BioNTech SE (BNTX) Germany $57.117B 41.42
Regeneron Pharmaceuticals (REGN) United States $56.897B 16.29
Biogen (BIIB) United States $56.368B 12.90
Vertex Pharmaceuticals (VRTX) United States $48.892B 20.14
Alexion Pharmaceuticals (ALXN) United States $39.702B 15.08
BeiGene (BGNE) Cayman Islands $30.598B 0.00
Seagen (SGEN) United States $28.797B 49.74
Genmab (GMAB) Denmark $28.414B 33.31
Genmab (GNMSF) Denmark $25.850B 5.95
Exact Sciences (EXAS) United States $21.948B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.984B 26.83
Incyte (INCY) United States $18.713B 37.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.020B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $17.185B 90.36
ARGENX SE-ADR (ARGX) Netherlands $16.203B 0.00
Zai Lab (ZLAB) China $15.229B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.828B 135.23
Novavax (NVAX) United States $14.402B 0.00
Guardant Health (GH) United States $12.480B 0.00
CureVac (CVAC) Germany $10.860B 0.00
Repligen (RGEN) United States $10.824B 97.60
QIAGEN (QGEN) Netherlands $10.818B 19.21
CRISPR Therapeutics AG (CRSP) Switzerland $9.789B 0.00
Mirati Therapeutics (MRTX) United States $8.491B 0.00
Denali Therapeutics (DNLI) United States $8.379B 300.61
Fate Therapeutics (FATE) United States $7.656B 0.00
Acceleron Pharma (XLRN) United States $7.555B 0.00
Ascendis Pharma (ASND) Denmark $7.536B 0.00
Exelixis (EXEL) United States $7.155B 114.15
Ultragenyx Pharmaceutical (RARE) United States $6.395B 0.00
Sarepta Therapeutics (SRPT) United States $6.350B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.325B 0.00
Vir Biotechnology (VIR) United States $6.199B 0.00
Halozyme Therapeutics (HALO) United States $6.130B 33.63
AbCellera Biologics (ABCL) $5.979B 0.00
Twist Bioscience (TWST) United States $5.808B 0.00
I-Mab (IMAB) China $5.727B 0.00
Adaptive Biotechnologies (ADPT) United States $5.570B 0.00
Beam Therapeutics (BEAM) United States $5.381B 0.00
Intellia Therapeutics (NTLA) United States $5.378B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.325B 19.29
Legend Biotech (LEGN) United States $5.282B 0.00
NeoGenomics (NEO) United States $5.236B 888.00
Apellis Pharmaceuticals (APLS) United States $5.129B 0.00
Reata Pharmaceuticals (RETA) United States $5.091B 0.00
Blueprint Medicines (BPMC) United States $4.842B 14.74
Galapagos (GLPG) Belgium $4.700B 0.00
Certara (CERT) United States $4.155B 0.00
SpringWorks Therapeutics (SWTX) United States $4.090B 0.00
Arena Pharmaceuticals (ARNA) United States $4.059B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.985B 0.00
Alkermes (ALKS) Ireland $3.889B 0.00
Arvinas (ARVN) United States $3.642B 0.00
Intra-Cellular Therapies (ITCI) United States $3.614B 0.00
Berkeley Lights (BLI) United States $3.333B 0.00
Emergent Biosolutions (EBS) United States $3.154B 6.28
Dicerna Pharmaceuticals (DRNA) United States $2.861B 0.00
Insmed (INSM) United States $2.858B 0.00
Vericel (VCEL) United States $2.830B 763.25
BAVARIAN NORDIC (BVNRY) Denmark $2.814B 0.00
Amicus Therapeutics (FOLD) United States $2.631B 0.00
Sorrento Therapeutics (SRNE) United States $2.567B 0.00
MorphoSys AG (MOR) Germany $2.546B 0.00
Editas Medicine (EDIT) United States $2.470B 0.00
Heska (HSKA) United States $2.358B 1028.18
Instil Bio (TIL) United States $2.334B 0.00
Myriad Genetics (MYGN) United States $2.303B 0.00
ALX Oncology Holdings (ALXO) United States $2.288B 0.00
Global Blood Therapeutics (GBT) United States $2.243B 0.00
Revance Therapeutics (RVNC) United States $2.241B 0.00
Bluebird Bio (BLUE) United States $2.211B 0.00
Morphic Holding (MORF) United States $2.186B 0.00
Ligand Pharmaceuticals (LGND) United States $2.158B 36.10
Seres Therapeutics (MCRB) United States $2.139B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.086B 0.00
Seer (SEER) $2.065B 0.00
Kymera Therapeutics (KYMR) United States $2.003B 0.00
Prothena (PRTA) Ireland $2.002B 0.00
Bionano Genomics (BNGO) United States $1.988B 0.00
Myovant Sciences (MYOV) United Kingdom $1.977B 0.00
Atea Pharmaceuticals (AVIR) United States $1.940B 0.00
Protagonist Therapeutics (PTGX) United States $1.907B 0.00
Castle Biosciences (CSTL) United States $1.885B 0.00
Genetron Holdings (GTH) China $1.881B 0.00
Inovio Pharmaceuticals (INO) United States $1.822B 0.00
Amarin (AMRN) Ireland $1.796B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.773B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.719B 0.00
PHARMA MAR SA (PHMMF) Spain $1.705B 0.00
Alector (ALEC) United States $1.699B 0.00
Zymeworks (ZYME) Canada $1.673B 0.00
C4 Therapeutics (CCCC) United States $1.656B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
REGENXBIO (RGNX) United States $1.621B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.617B 0.00
Arcus Biosciences (RCUS) United States $1.615B 0.00
Cytokinetics (CYTK) United States $1.589B 0.00
NGM Biopharmaceuticals (NGM) United States $1.566B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.481B 0.00
Ocugen (OCGN) United States $1.469B 0.00
Avid Bioservices (CDMO) United States $1.447B 0.00
PureTech Health (PRTC) United States $1.421B 0.00
UniQure (QURE) Netherlands $1.405B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.373B 0.00
Codexis (CDXS) United States $1.350B 0.00
Precigen (PGEN) United States $1.300B 0.00
BioAtla (BCAB) United States $1.297B 0.00
MiMedx (MDXG) United States $1.286B 0.00
Zealand Pharma (ZEAL) Denmark $1.283B 0.00
Nurix Therapeutics (NRIX) United States $1.280B 0.00
Shattuck Labs (STTK) United States $1.236B 0.00
Northwest Biotherapeutics (NWBO) United States $1.236B 0.00
Keros Therapeutics (KROS) United States $1.225B 0.00
Repare Therapeutics (RPTX) Canada $1.203B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.190B 0.00
Agenus (AGEN) United States $1.152B 0.00
Coherus BioSciences (CHRS) United States $1.142B 0.00
Celldex Therapeutics (CLDX) United States $1.139B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
Mesoblast (MESO) Australia $1.114B 0.00
MannKind (MNKD) United States $1.111B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.091B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.044B 32.97
Scholar Rock Holding (SRRK) United States $1.032B 0.00
Dynavax Technologies (DVAX) United States $1.026B 0.00
Pliant Therapeutics (PLRX) United States $1.021B 0.00
VBI Vaccines (VBIV) United States $0.989B 0.00
Mersana Therapeutics (MRSN) United States $0.981B 0.00
Inhibrx (INBX) United States $0.948B 0.00
Avidity Biosciences (RNA) United States $0.943B 0.00
Epizyme (EPZM) United States $0.913B 0.00
Cel-Sci (CVM) United States $0.910B 0.00
Travere Therapeutics (TVTX) United States $0.901B 0.00
G1 THERAPEUTICS (GTHX) United States $0.899B 0.00
Nkarta (NKTX) United States $0.889B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.869B 0.00
RAPT THERAPTICS (RAPT) United States $0.869B 0.00
Prometheus Biosciences (RXDX) United States $0.860B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.858B 0.00
Sutro Biopharma (STRO) United States $0.850B 0.00
Merus (MRUS) Netherlands $0.834B 0.00
Affimed (AFMD) Germany $0.810B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.748B 0.00
Verastem (VSTM) United States $0.736B 0.00
SESEN BIO, INC (SESN) United States $0.717B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
IDEAYA Biosciences (IDYA) United States $0.707B 0.00
Pharming Group (PHAR) Netherlands $0.702B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.700B 0.00
Cara Therapeutics (CARA) United States $0.695B 60.39
Pharming Group (PHGUF) Netherlands $0.688B 18.33
Curis (CRIS) United States $0.688B 0.00
MeiraGTx Holdings (MGTX) United States $0.684B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.682B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.676B 0.00
AnaptysBio (ANAB) United States $0.675B 0.00
ALBIREO PHARMA (ALBO) United States $0.667B 0.00
Cellectis S.A (CLLS) France $0.664B 0.00
Kadmon Holdings (KDMN) United States $0.657B 0.00
Clene (CLNN) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
DBV Technologies S.A (DBVT) France $0.635B 0.00
Clovis Oncology (CLVS) United States $0.615B 0.00
Anika Therapeutics (ANIK) United States $0.614B 0.00
Precision BioSciences (DTIL) United States $0.612B 0.00
Adagene (ADAG) China $0.610B 0.00
ChromaDex (CDXC) United States $0.603B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.600B 0.00
Bolt Biotherapeutics (BOLT) United States $0.581B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.577B 0.00
AC Immune SA (ACIU) Switzerland $0.572B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.535B 0.00
Compugen (CGEN) Israel $0.525B 0.00
Selecta Biosciences (SELB) United States $0.515B 0.00
Forte Biosciences (FBRX) United States $0.501B 0.00
Geron (GERN) United States $0.500B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.492B 0.00
XBiotech (XBIT) United States $0.486B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.478B 0.00
Starpharma Holdings (SPHRY) Australia $0.472B 0.00
Codiak BioSciences (CDAK) United States $0.468B 0.00
Gritstone Bio (GRTS) United States $0.457B 0.00
CytomX Therapeutics (CTMX) United States $0.451B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.444B 0.00
Athenex (ATNX) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.440B 0.00
Neoleukin Therapeutics (NLTX) United States $0.423B 0.00
Spero Therapeutics (SPRO) United States $0.422B 0.00
Amryt Pharma (AMYT) United Kingdom $0.420B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
ANI Pharmaceuticals (ANIP) United States $0.410B 11.32
Oncobiologics (OTLK) United States $0.406B 0.00
AquaBounty Technologies (AQB) United States $0.405B 0.00
Puma Biotechnology (PBYI) United States $0.396B 0.00
Angion Biomedica (ANGN) United States $0.387B 0.00
Cue Biopharma (CUE) United States $0.384B 0.00
Kala Pharmaceuticals (KALA) United States $0.369B 0.00
Theratechnologies (THTX) Canada $0.360B 0.00
SQZ Biotechnologies (SQZ) United States $0.359B 0.00
Adverum Biotechnologies (ADVM) United States $0.355B 0.00
BioDelivery Sciences (BDSI) United States $0.352B 14.28
XOMA (XOMA) United States $0.346B 161.63
UROGEN PHARMA (URGN) United States $0.344B 0.00
Fortress Biotech (FBIO) United States $0.343B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.337B 0.00
Opthea (OPT) Australia $0.334B 0.00
Cerecor (CERC) United States $0.334B 0.00
Frequency Therapeutics (FREQ) United States $0.330B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.329B 0.00
Cogent Biosciences (COGT) United States $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.322B 0.00
Athersys (ATHX) United States $0.320B 0.00
IBio (IBIO) United States $0.318B 0.00
Prima BioMed (IMMP) Australia $0.310B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
Trevena (TRVN) United States $0.308B 0.00
Adicet Bio (ACET) United States $0.300B 0.00
Arbutus Biopharma (ABUS) United States $0.299B 0.00
Fulcrum Therapeutics (FULC) United States $0.291B 0.00
CorMedix Inc (CRMD) United States $0.289B 0.00
OVID THERAPEUTC (OVID) United States $0.289B 2.84
Cardiff Oncology (CRDF) United States $0.288B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Kaleido Biosciences (KLDO) $0.279B 0.00
Innate Pharma S.A (IPHA) France $0.276B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.271B 0.00
Bellus Health (BLU) Canada $0.262B 0.00
Clearside Biomedical (CLSD) United States $0.261B 0.00
Kamada (KMDA) Israel $0.258B 17.58
Talis Biomedical (TLIS) United States $0.258B 0.00
INmune Bio (INMB) United States $0.256B 0.00
HOOKIPA Pharma (HOOK) United States $0.242B 0.00
Chiasma (CHMA) United States $0.240B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.232B 0.00
Seelos Therapeutics (SEEL) United States $0.225B 0.00
TELA Bio (TELA) United States $0.224B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Synlogic (SYBX) United States $0.222B 0.00
NextCure (NXTC) United States $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.215B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
VTv Therapeutics (VTVT) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Aptinyx (APTX) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.189B 0.00
Biofrontera AG (BFRA) Germany $0.186B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.183B 0.00
Galena Biopharma (SLS) United States $0.179B 0.00
OSMOTICA PHARM (OSMT) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.178B 0.00
Applied Genetic Technologies (AGTC) United States $0.177B 0.00
X4 Pharmaceuticals (XFOR) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
ObsEva SA (OBSV) Switzerland $0.169B 0.00
PHASEBIO PHARMA (PHAS) United States $0.166B 0.00
Abeona Therapeutics (ABEO) United States $0.163B 0.00
VolitionRX (VNRX) United States $0.161B 0.00
Voyager Therapeutics (VYGR) United States $0.160B 4.11
Antibe Therapeutics (ATBPF) Canada $0.158B 0.00
Cyclerion Therapeutics (CYCN) United States $0.150B 0.00
Enzo Biochem (ENZ) United States $0.146B 43.00
Longeveron (LGVN) United States $0.141B 0.00
Aytu BioPharma (AYTU) United States $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
Eyenovia (EYEN) United States $0.138B 0.00
Liquidia Technologies (LQDA) United States $0.137B 0.00
Exicure (XCUR) United States $0.136B 0.00
Beyond Air (XAIR) United States $0.135B 0.00
DiaMedica Therapeutics (DMAC) United States $0.133B 0.00
ABVC BioPharma (ABVC) United States $0.133B 0.00
Catalyst Biosciences (CBIO) United States $0.133B 0.00
Erytech Pharma SA (ERYP) France $0.132B 0.00
LogicBio Therapeutics (LOGC) United States $0.130B 0.00
Cocrystal Pharma (COCP) United States $0.128B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.127B 0.00
Novogen (KZIA) Australia $0.126B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Liminal BioSciences (LMNL) Canada $0.122B 0.00
Palatin Technologies (PTN) United States $0.122B 0.00
Evofem Biosciences (EVFM) United States $0.119B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.117B 0.00
Yumanity Therapeutics (YMTX) United States $0.115B 0.00
Orgenesis (ORGS) United States $0.113B 231.50
Vyant Bio (VYNT) United States $0.110B 0.00
Celsion (CLSN) United States $0.108B 0.00
Vascular Biogenics (VBLT) Israel $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.107B 0.00
Entera Bio (ENTX) Israel $0.106B 0.00
AEterna Zentaris (AEZS) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.106B 0.00
Aptevo Therapeutics (APVO) United States $0.105B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
TRACON Pharmaceuticals (TCON) United States $0.099B 0.00
Zosano Pharma (ZSAN) United States $0.098B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
Lumos Pharma (LUMO) United States $0.091B 0.00
Evogene (EVGN) Israel $0.088B 0.00
AIkido Pharma (AIKI) United States $0.086B 0.00
Protalix BioTherapeutics (PLX) Israel $0.085B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.085B 0.00
BioCardia (BCDA) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.081B 0.00
Purple Biotech (PPBT) Israel $0.080B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Vaccinex (VCNX) United States $0.076B 0.00
Celyad SA (CYAD) Belgium $0.076B 0.00
Cleveland BioLabs (CBLI) United States $0.076B 0.00
ARIDIS PHARMACT (ARDS) United States $0.075B 0.00
ATyr Pharma (LIFE) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
Viridian Therapeutics (VRDN) United States $0.068B 0.00
Advaxis (ADXS) United States $0.068B 0.00
Cyclo Therapeutics (CYTH) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Genetic Technologies (GENE) Australia $0.061B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.058B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
Windtree Therapeutics (WINT) United States $0.056B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.053B 0.00
AnPac Bio-Medical Science (ANPC) China $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 1.11
Soligenix (SNGX) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.045B 0.00
Timber Pharmaceuticals (TMBR) United States $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
Vallon Pharmaceuticals (VLON) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
GeoVax Labs (GOVX) United States $0.032B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
ThermoGenesis Holdings (THMO) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
ZIVO Bioscience (ZIVO) United States $0.023B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00